Sphera Funds Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Sphera Funds Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$25.5M	Buy	200,000 +130,000	+186%	+$16.2M	4.06%	4
2025 Q4	$8.54M	Buy	+70,000	New	+$8.03M	1.65%	15
2025 Q3	–	Sell	-200,000	Closed	-$16.6M	–	141
2025 Q2	$16.6M	Buy	+200,000	New	+$16M	3.89%	3
2024 Q2	–	Sell	-380,000	Closed	-$36.1M	–	135
2024 Q1	$36.1M	Sell	380,000 -120,000	-24%	-$11.1M	5.07%	2
2023 Q4	$44.6M	Buy	+500,000	New	+$37.1M	7.19%	1
2021 Q4	–	Sell	-400,000	Closed	-$50.3M	–	126
2021 Q3	$50.3M	Sell	400,000 -225,000	-36%	-$29M	4.22%	4
2021 Q2	$84.6M	Buy	+625,000	New	+$82.2M	5.72%	1
2021 Q1	–	Sell	-300,000	Closed	-$42.2M	–	204
2020 Q4	$42.2M	Buy	+300,000	New	+$38.4M	3.75%	5
2020 Q3	–	Sell	-750,000	Closed	-$84M	–	117
2020 Q2	$84M	Buy	750,000 +250,000	+50%	+$24.6M	7.9%	1
2020 Q1	$38.7M	Sell	500,000 -2,300,000	-82%	-$204M	4.84%	7
2019 Q4	$266M	Buy	+2,800,000	New	+$242M	21.95%	1
2019 Q2	–	Sell	-3,335,000	Closed	-$302M	–	109
2019 Q1	$302M	Buy	3,335,000 +635,000	+24%	+$54M	27.56%	1
2018 Q4	$194M	Buy	2,700,000 +1,600,000	+145%	+$129M	21.84%	1
2018 Q3	$105M	Buy	+1,100,000	New	+$107M	12.11%	1
2018 Q2	–	Sell	-750,000	Closed	-$65.8M	–	127
2018 Q1	$65.8M	Sell	750,000 -1,200,000	-62%	-$110M	9.99%	1
2017 Q4	$165M	Buy	1,950,000 +550,000	+39%	+$46.1M	19.42%	1
2017 Q3	$121M	Buy	+1,400,000	New	+$112M	17.29%	1

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Sphera Funds Management's XBI Position: Q4 2023 in Review

Sphera Funds Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2023, closing a stake of 50,000 shares — an estimated $3.71M sold.

Sphera Funds Management first reported a position in XBI in Q4 2018 and held it in 5 quarters. The position peaked at $32.5M in Q2 2022. 745 funds tracked by Wall St. Rank hold XBI as of Q4 2023.

Sphera Funds Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2023 after selling out during the quarter.
Sphera Funds Management sold 50,000 State Street SPDR S&P Biotech ETF shares in Q4 2023, an estimated $3.71M.
Sphera Funds Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2018 and held it in 5 quarters.
Sphera Funds Management's State Street SPDR S&P Biotech ETF position peaked at $32.5M in Q2 2022.
745 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2023.

Based on Sphera Funds Management's 13F filing for Q4 2023, filed 14 Feb 2024.